Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-010594

Chief Financial Officer sold 61,883 shares

  • Chief Financial Officer acquired 61,883 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Somaiya Mayur Ian · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-27 Exercise or conversion : show line 1 in the form 10b5-1 +46,983 $9.26 $435,063 84,983 D
2025-01-27 Sale : show line 2 in the form 10b5-1 −33,679 51,304 D
2025-01-27 Sale : show line 3 in the form 10b5-1 −13,304 38,000 D
2025-01-28 Exercise or conversion : show line 4 in the form 10b5-1 +14,900 $9.26 $137,974 52,900 D
2025-01-28 Sale : show line 5 in the form 10b5-1 −11,495 41,405 D
2025-01-28 Sale : show line 6 in the form 10b5-1 −3,405 38,000 D
Open-market sales · 61,883 sh

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-27 Exercise or conversion : show line 7 in the form 10b5-1 Option (Right to Buy) −46,983 777,714 D
2025-01-28 Exercise or conversion : show line 8 in the form 10b5-1 Option (Right to Buy) −14,900 762,814 D
Loading xslF345X05/ownership.xml…